GenAI: From Task Replacement to Workflow Revolution

The Hidden Crisis: Why Brilliant Research Dies in Digital Graveyards

What if your organisation's most valuable research insights are sitting unused, lost in digital graveyards?

The hard truth: we've created a cycle in HEOR that's bleeding resources and hindering innovative progress. Here's what's happening behind closed doors:

• A significant portion of valuable research and documentation — often spanning hundreds of pages — remains confined to a single, specific purpose or a small team.
• Broader study findings and deeper understandings often remain known only to the principal investigator or the team directly involved, rarely permeating wider organisational functions.
• These reports frequently reside in isolated digital folders or even on individual researchers' computers, severely limiting their potential reach and impact.
• Organisations may initiate entirely new studies to answer questions already addressed, simply because previous findings are buried and inaccessible.

The result? Months of duplicated effort, countless researcher hours, and substantial budget losses on questions already answered. This isn't just inefficiency — it's organisational amnesia that prevents us from building on our collective intelligence. Every buried insight represents a missed opportunity to advance patient care faster.

The question isn't whether you have valuable research sitting unused. The question is: how much is this costing you?

Beyond Automation: GenAI as the Evidence Democratiser

In my view, most organisations are thinking too small about GenAI in HEOR.

Current focus: Replacing tasks (like document summarisation or data extraction).

The bigger opportunity: Democratising access to institutional knowledge.

While automating existing workflows offers immediate gains, the real revolution will happen at a deeper level. GenAI doesn't just process data faster — it can transform vast amounts of unstructured clinical and research data into accessible, actionable intelligence.

This is about moving from "expert gatekeepers" to "universal access." Imagine if every team member could instantly access the collective wisdom of your organisation's research — not just summaries, but the nuanced insights that currently live only in researchers' heads.

This isn't just efficiency. This is democratisation of expertise. GenAI's capacity to unlock the "dark matter" of unstructured data can be the key to solving HEOR's decades-old problem of translating raw data into meaningful, actionable and accessible insight.

The organisations that will lead tomorrow won't be those with the smartest individuals — they'll be those that make their collective intelligence accessible to everyone.

The Workflow Revolution Is Coming

We're not just automating tasks — we're about to enter a phase that will fundamentally reshape how knowledge flows through organisations. Most current use cases focus on replacing tasks in existing workflows. But soon, we'll see workflows themselves transform.

Three areas where disruption is emerging:

1. Information Dissemination Revolution

• From static reports to conversational AI that "knows" your research
• From email chains to AI agents that proactively surface relevant insights
• From PowerPoint presentations to interactive knowledge exploration

2. Training & Knowledge Transfer

• New employee onboarding accelerated from months to weeks
• Real-time expert guidance through AI mentors
• Institutional memory becomes immortal and accessible

3. Decision-Making Transformation

• From lengthy committee meetings to AI-assisted, issue-focused huddles
• From gut instinct to evidence-based recommendations in real-time

This isn't about working faster in the same way. This is about working in entirely new ways. There is still much to learn and figure out, but the movement has certainly started.

Promising Experiments Across the Industry

This isn't theoretical — initial work is showing very promising results, pointing towards transformational impacts across Life Sciences:

• Commercial Analytics: Early reports indicate significantly reduced time for insights, enabling faster commercial decisions with high accuracy.
• Clinical Development: AI is optimising clinical trial protocols, suggesting potential for fewer amendments and increased patient enrolment.
• Regulatory Affairs: Initial applications show potential for dramatically reduced Health Authority query response times and faster drafting of regulatory documents.
• Medical Affairs: Promising time cuts for creating critical response documents have been observed.
• Knowledge Management: AI-powered tools are enhancing accessibility and retrieval of organisational knowledge, contributing to improved productivity and reduced service costs.

The pattern emerging is that organisations are not just achieving incremental improvements — they are seeing the potential for order-of-magnitude transformations that could create long-term competitive advantages.

The Choice: Lead or Follow

The question isn't whether GenAI will transform HEOR — it's whether you'll lead the transformation or be disrupted by it.

Success requires robust governance frameworks and ongoing monitoring to mitigate risks around bias, hallucinations, and regulatory compliance. The most effective implementations maintain human oversight for validation and ethical decision-making.

The future of HEOR belongs to organisations that strategically invest in developing their AI capabilities, turning their collective intelligence into a competitive weapon. The technology exists. The initial results are very promising. The regulatory pathways are being worked on.

The question is: Will you wait for someone to figure things out, or will you lead the transformation?